@article{ff2d376422454f918b974672991d14da,
title = "Scenario 2: A patient with ventilator-associated bacterial pneumonia-introduction to clinical trial design issues",
abstract = "A prototypical patient is presented to introduce important design issues for clinical trials of antibacterials in the treatment of ventilator-associated bacterial pneumonia.",
author = "Gilbert, \{David N.\}",
note = "Funding Information: Supplement sponsorship. This article was published as part of a supplement entitled “Workshop on Issues in the Design of Clinical Trials for Antibacterial Drugs for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia,” sponsored by the US Food and Drug Administration, Infectious Diseases Society of America, American College of Chest Physicians, American Thoracic Society, and the Society of Critical Care Medicine, with financial support from the Pharmaceutical Research and Manufacturers of America, AstraZeneca Pharmaceuticals, and Forest Pharmaceuticals.",
year = "2010",
month = aug,
day = "1",
doi = "10.1086/653056",
language = "English",
volume = "51",
pages = "S100--S102",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "SUPPL. 1",
}